Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Key trends in interventional cardiology | Valve durability after TAVR | Late-breakers announced for ACC.25

News You Need to Know Today
Key trends in interventional cardiology | Valve durability after TAVR | Late-breakers announced for ACC.25
Friday, January 24, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New directions and trends in interventional cardiology

Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business. 

READ MORE >
George Dangas, MD, 2023-24 president of SCAI, director of cardiovascular innovation at Mount Sinai Hospital, and director of the TCT meeting, explains key trends he sees in interventional cardiology.
Share on Twitter Share on Facebook Share on Linkedin

New directions and trends in interventional cardiology

Share on Twitter Share on Facebook Share on Linkedin
George Dangas, MD, 2023-24 president of SCAI, director of cardiovascular innovation at Mount Sinai Hospital, and director of the TCT meeting, explains key trends he sees in interventional cardiology.
Interventional cardiology continues to evolve, driven by rapid advancements in technology. George Dangas, MD, discussed some of the specialty's biggest ongoing trends with Cardiovascular Business. 
READ MORE >

Valve durability after TAVR: Cardiologists track how deterioration influences outcomes

Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Valve durability after TAVR: Cardiologists track how deterioration influences outcomes

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Researchers have made it a priority to learn as much about the durability of TAVR valves as possible. A new study in JACC: Cardiovascular Interventions used updated VARC-3 definitions to identify signs of hemodynamic valve deterioration in nearly 2,500 patients.
READ MORE >

AI-powered heart assessments of NFL veterans could help cardiologists tackle CVD

Retired NFL players Joel Dreessen and Le-Lo Lang are among the first athletes participating in a new registry launched by HeartFlow and the Boone Heart Institute.

READ MORE >
HeartFlow Plaque analysis AI software highlighting areas of interest in the coronaries with significant plaque burden and showing a cross sectional reformatted view with plaques. Demo at TCT 2024. DF
Share on Twitter Share on Facebook Share on Linkedin

AI-powered heart assessments of NFL veterans could help cardiologists tackle CVD

Share on Twitter Share on Facebook Share on Linkedin
HeartFlow Plaque analysis AI software highlighting areas of interest in the coronaries with significant plaque burden and showing a cross sectional reformatted view with plaques. Demo at TCT 2024. DF
Retired NFL players Joel Dreessen and Le-Lo Lang are among the first athletes participating in a new registry launched by HeartFlow and the Boone Heart Institute.
READ MORE >

American College of Cardiology announces late-breaking clinical trials for ACC.25

The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.

READ MORE >
ACC.24 sign American College of Cardiology
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology announces late-breaking clinical trials for ACC.25

Share on Twitter Share on Facebook Share on Linkedin
ACC.24 sign American College of Cardiology
The presentations will cover a variety of topics, including coronary artery disease, semaglutide, artificial intelligence, TAVR, heart failure, PCI and much more. ACC.25 takes place March 29-31 in Chicago.
READ MORE >

Featured Articles

Cardiologist sues health system over gender discrimination, unequal pay and hostile treatment

The veteran doctor says she was treated “vastly different from her male counterparts” during her 17 years with Lehigh Valley Health Network.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist sues health system over gender discrimination, unequal pay and hostile treatment

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The veteran doctor says she was treated “vastly different from her male counterparts” during her 17 years with Lehigh Valley Health Network.
READ MORE >

Surgeons make history again with world’s first robotic implant of Abbott heart device

The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.

READ MORE >
King Faisal Specialist Hospital and Research Center perform LVAD implant with robotic assistance
Share on Twitter Share on Facebook Share on Linkedin

Surgeons make history again with world’s first robotic implant of Abbott heart device

Share on Twitter Share on Facebook Share on Linkedin
King Faisal Specialist Hospital and Research Center perform LVAD implant with robotic assistance
The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.
READ MORE >

Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards

Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.

READ MORE >
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
Share on Twitter Share on Facebook Share on Linkedin

Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards

Share on Twitter Share on Facebook Share on Linkedin
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
READ MORE >

In Case You Missed It

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.

READ MORE >
STS President Jennifer C. Romano, MD, MS, a congenital heart surgeon with Mott Children’s Hospital and professor with the University of Michigan (UM) Medical School, spoke with Cardiovascular Business to preview STS 2025.
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

Share on Twitter Share on Facebook Share on Linkedin
STS President Jennifer C. Romano, MD, MS, a congenital heart surgeon with Mott Children’s Hospital and professor with the University of Michigan (UM) Medical School, spoke with Cardiovascular Business to preview STS 2025.
It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.
READ MORE >

FDA has now cleared more than 1,000 AI models, including many in cardiology

Cardiology is the medical speciality with the second most FDA clearances overall. 

READ MORE >
GE Healthcare's CardIQ Suite offers AI to help automated cardiac CT assessments, including measurement of vessels and anatomy, visualization of chamber mobility, plaque imaging and calcium scoring. Photo by Dave FornellCoronary CCTA cardiac CT training for interventional cardiologists, GE session at TCT 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

FDA has now cleared more than 1,000 AI models, including many in cardiology

Share on Twitter Share on Facebook Share on Linkedin
GE Healthcare's CardIQ Suite offers AI to help automated cardiac CT assessments, including measurement of vessels and anatomy, visualization of chamber mobility, plaque imaging and calcium scoring. Photo by Dave FornellCoronary CCTA cardiac CT training for interventional cardiologists, GE session at TCT 2023. Photo by Dave Fornell
Cardiology is the medical speciality with the second most FDA clearances overall. 
READ MORE >

Robotic mitral repair compares favorably to surgery—but some concerns remain

Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Robotic mitral repair compares favorably to surgery—but some concerns remain

Share on Twitter Share on Facebook Share on Linkedin
Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.
READ MORE >

In Other News

Congress hesitates on long-term telemedicine expansion admid advocacy push

Congress temporarily extended telemedicine provisions until March amid lobby efforts by the Medical Group Management Association (MGMA) and others to make the provisions permanent.

READ MORE >
MGMA's Anders Gilberg calls on CMS and Congress to extend telemedicine and highlights the issues involved.
Share on Twitter Share on Facebook Share on Linkedin

Congress hesitates on long-term telemedicine expansion admid advocacy push

Share on Twitter Share on Facebook Share on Linkedin
MGMA's Anders Gilberg calls on CMS and Congress to extend telemedicine and highlights the issues involved.
Congress temporarily extended telemedicine provisions until March amid lobby efforts by the Medical Group Management Association (MGMA) and others to make the provisions permanent.
READ MORE >

State lawmaker wants increased scrutiny around Rad Partners affiliate Jefferson Radiology

Republican Sen. Jeffrey Gordon, MD, said Wednesday that he has heard from a dozen constituents about the issue and also discussed it with his physician colleagues. 

READ MORE >
Republican Sen. Jeffrey Gordon, MD
Share on Twitter Share on Facebook Share on Linkedin

State lawmaker wants increased scrutiny around Rad Partners affiliate Jefferson Radiology

Share on Twitter Share on Facebook Share on Linkedin
Republican Sen. Jeffrey Gordon, MD
Republican Sen. Jeffrey Gordon, MD, said Wednesday that he has heard from a dozen constituents about the issue and also discussed it with his physician colleagues. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup